SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012865
Filing Date
2022-08-09
Accepted
2022-08-09 16:06:27
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20220630x10q.htm   iXBRL 10-Q 1540232
2 EX-31.1 idra-20220630xex31d1.htm EX-31.1 13882
3 EX-31.2 idra-20220630xex31d2.htm EX-31.2 13592
4 EX-32.1 idra-20220630xex32d1.htm EX-32.1 7140
5 EX-32.2 idra-20220630xex32d2.htm EX-32.2 7749
6 GRAPHIC idra-20220630x10q004.jpg GRAPHIC 6453
  Complete submission text file 0001558370-22-012865.txt   6631641

Data Files

Seq Description Document Type Size
7 EX-101.SCH idra-20220630.xsd EX-101.SCH 48523
8 EX-101.CAL idra-20220630_cal.xml EX-101.CAL 35052
9 EX-101.DEF idra-20220630_def.xml EX-101.DEF 196677
10 EX-101.LAB idra-20220630_lab.xml EX-101.LAB 367226
11 EX-101.PRE idra-20220630_pre.xml EX-101.PRE 315365
58 EXTRACTED XBRL INSTANCE DOCUMENT idra-20220630x10q_htm.xml XML 1244133
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 221148255
SIC: 2836 Biological Products, (No Diagnostic Substances)